4.7 Article

Role of resection margins in patients treated with breast conservation surgery

期刊

CANCER
卷 112, 期 9, 页码 1923-1931

出版社

WILEY
DOI: 10.1002/cncr.23383

关键词

breast cancer; breast conservation surgery; margins; reexcision

类别

向作者/读者索取更多资源

BACKGROUND. After breast conservation therapy (BCT), margin status is routinely evaluated to select patients who need reexcision. The aim of this study was to investigate how margin status and other clinicopathologic factors correlate with the presence of residual tumor at reexcision. METHODS. A series of 431 breast cancer patients who underwent BCT followed by reexcision were considered because they had positive or close (<= 3 mm) margins. At univariate and multivariate analysis the frequency of residual tumor in the reexcision specimens was associated with the status and width of resection margins and with a series of other clinicopathologic factors. RESULTS. Of the 382 evaluable patients, 253 had positive and 129 close margins. Residual tumor was found at reexcision in 51.8% positive-margin patients and 34.1% close-margin patients (P=.001). In the latter group tumor-margin distance (range, 0.08 to 3 mm) was not associated with the incidence of residual tumor (P =.134). On univariate analysis age <= 45 years (P =.006), intraductal histotype (P =.005), size > 2 cm (P =.010), positive axillary nodes (P =.031), and timing of reexcision (P =.044) were significantly associated with a higher frequency of residual tumor. All these factors, except tumor size, maintained a significant predictive value on multivariate analysis. CONCLUSIONS. In the presence of positive margins, relevant residual disease cannot be ruled out and further Surgery is indicated. Close margins do not mandate reexcision because they may indicate either that the tumor has been radically excised or the presence of residual foci of a multifocal tumor, which are usually effectively treated by radiotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Long-Term Outcomes Using Electron IOERT APBI for Early Stage Breast Cancer: The Verona University Hospital Experience

Nunzia Luna Valentina Cernusco, Paola Del Bianco, Mario Romano, Alessandro Muraglia, Gabriella Rossi, Maria Grazia Giri, Stefania Guariglia, Davide Lombardi, Francesca Pellini, Carlo Cavedon, Giovanni Paolo Pollini, Renzo Mazzarotto

Summary: This study evaluated the long-term outcomes of intraoperative electron accelerated partial breast radiotherapy (IOERT APBI) in 295 patients suitable for breast-conserving therapy. The results suggest that a single-dose IOERT can be safely delivered with excellent outcomes and very low long-term recurrence rates in highly selected early stage breast cancer patients.

CLINICAL BREAST CANCER (2022)

Article Oncology

Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella, Cinzia Sassaroli, Massimo Framarini, Mario Valle, Antonio Macri, Luigina Graziosi, Federico Coccolini, Piero Vincenzo Lippolis, Gelmini Roberta, Marcello Deraco, Daniele Biacchi, Francesco Santullo, Marco Vaira, Katia Di Lauro, Fabrizio D'Acapito, Fabio Carboni, Giuseppe Giuffre, Annibale Donini, Paola Fugazzola, Pinuccia Faviana, Sorrentino Lorena, Antonio Scapinello, Paola Del Bianco, Antonio Sommariva

Summary: This study highlights the prognostic significance of KRAS/BRAF mutations and micro-satellite status in colorectal peritoneal metastases patients undergoing CRS. MSI status is associated with longer survival, even in mutated patients. Integrating clinical, pathological, and molecular features is crucial for treatment decisions in these patients.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial

Francesco Marchegiani, Valeria Palatucci, Giulia Capelli, Mario Guerrieri, Claudio Belluco, Daniela Rega, Emilio Morpurgo, Claudio Coco, Angelo Restivo, Silvia De Franciscis, Carlo Aschele, Alessandro Perin, Michele Bonomo, Andrea Muratore, Antonino Spinelli, Salvatore Ramuscello, Francesca Bergamo, Giampaolo Montesi, Gaya Spolverato, Paola Del Bianco, Maria Antonietta Gambacorta, Paolo Delrio, Salvatore Pucciarelli

Summary: The short-term outcomes of rectum-preservation for locally advanced rectal cancer patients achieving major clinical response or complete clinical response after neoadjuvant therapy were reported in the study. Transanal local excision for patients achieving cCR or mCR is safe, with an increased cCR rate seen when there is a 12-week interval from chemoradiotherapy completion to LE. Performing LE after achieving cCR reduces the risk of ypT >.

ANNALS OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ASO Visual Abstract: Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial

Francesco Marchegiani, Valeria Palatucci, Giulia Capelli, Mario Guerrieri, Claudio Belluco, Daniela Rega, Emilio Morpurgo, Claudio Coco, Angelo Restivo, Silvia De Franciscis, Carlo Aschele, Alessandro Perin, Michele Bonomo, Andrea Muratore, Antonino Spinelli, Salvatore Ramuscello, Francesca Bergamo, Giampaolo Montesi, Gaya Spolverato, Paola Del Bianco, Maria Antonietta Gambacorta, Paolo Delrio, Salvatore Pucciarelli

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Immunology

Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients

Paola Del Bianco, Laura Pinton, Sara Magri, Stefania Cane, Elena Masetto, Daniela Basso, Marta Padovan, Francesco Volpin, Domenico d'Avella, Giuseppe Lombardi, Vittorina Zagonel, Vincenzo Bronte, Alessandro Della Puppa, Susanna Mandruzzato

Summary: This study highlights the role of systemic immune suppression carried out by myeloid cells in gliomas and identifies biomarkers associated with the immune landscape, diagnosis, and outcome of glioblastoma patients.

FRONTIERS IN IMMUNOLOGY (2022)

Correction Oncology

Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (Nov, 10.1245/S10434-021-11045-3, 2021)

Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella, Cinzia Sassaroli, Massimo Framarini, Mario Valle, Antonio Macri, Luigina Graziosi, Federico Coccolini, Piero Vincenzo Lippolis, Roberta Gelmini, Marcello Deraco, Daniele Biacchi, Francesco Santullo, Marco Vaira, Katia Di Lauro, Fabrizio D'Acapito, Fabio Carboni, Giuseppe Giuffre, Annibale Donini, Paola Fugazzola, Pinuccia Faviana, Lorena Sorrentino, Antonio Scapinello, Paola Del Bianco, Antonio Sommariva

ANNALS OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ASO Visual Abstract: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella, Cinzia Sassaroli, Massimo Framarini, Mario Valle, Antonio Macri, Luigina Graziosi, Federico Coccolini, Piero Vincenzo Lippolis, Roberta Gelmini, Marcello Deraco, Daniele Biacchi, Francesco Santullo, Marco Vaira, Katia Di Lauro, Fabrizio D'Acapito, Fabio Carboni, Giuseppe Giuffre, Annibale Donini, Paola Fugazzola, Pinuccia Faviana, Lorena Sorrentino, Antonio Scapinello, Paola Del Bianco, Antonio Sommariva

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Public, Environmental & Occupational Health

Impact of Wide Local Excision on Melanoma Patient Survival: A Population-Based Study

Alessandra Buja, Massimo Rugge, Giovanni Damiani, Giuseppe De Luca, Manuel Zorzi, Riccardo Fusinato, Chiara De Toni, Antonella Vecchiato, Paolo Del Fiore, Francesca Falasco, Romina Spina, Carlo Riccardo Rossi, Simone Mocellin

Summary: By combining clinical and administrative data, this study demonstrates that almost one in ten CMM patients did not undergo wide local excision surgery. Monitoring how diagnostic-therapeutic protocols are actually implemented in the real world may significantly contribute to promoting quality improvements in the management of oncological patients.

FRONTIERS IN PUBLIC HEALTH (2022)

Article Oncology

Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the CARACAS study

Alessandra A. Prete, Paolo Manca, Marco Messina, Vincenzo Formica, Giovanni L. Frassineti, Maria G. Zampino, Domenico C. Corsi, Corrado Orciuolo, Michele Prisciandaro, Francesca Bergamo, Valentina Angerilli, Mario Scartozzi, Mariaelena Casagrande, Gianluca Masi, Monica Ronzoni, Federica Morano, Valentina Vettore, Roberta Salmaso, Cosimo Rasola, Giulia Maddalena, Paola del Bianco, Massimo Milione, Chiara Cremolini, Matteo Fassan, Filippo Pietrantonio, Sara Lonardi

Summary: This study found that patients with high PD-L1 and high TMB had better survival outcomes when treated with immune checkpoint inhibitors for advanced squamous cell anal carcinoma.

EUROPEAN JOURNAL OF CANCER (2023)

Article Oncology

Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade

Hayden Pearce, Wayne Croft, Samantha M. Nicol, Sandra Margielewska-Davies, Richard Powell, Richard Cornall, Simon J. Davis, Francesca Marcon, Matthew R. Pugh, Eanna Fennell, Sarah Powell-Brett, Brinder S. Mahon, Rachel M. Brown, Gary Middleton, Keith Roberts, Paul Moss

Summary: Pancreatic ductal adenocarcinoma (PDAC) has a poor clinical outlook, and a better understanding of the tumor immune microenvironment is needed. In this study, T cells were found to be the predominant immune cell subset within PDAC tumors. The presence of exhausted TRM cells expressing PD-1 and TIGIT suggests that dual checkpoint receptor blockade could be a promising avenue for future immunotherapy.

CANCER IMMUNOLOGY RESEARCH (2023)

Article Oncology

Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study

Federica Ferrarini, Elisabetta Zulato, Massimo Moro, Paola Del Bianco, Cristina Borzi, Giovanni Esposito, Tiziana Zanin, Gabriella Sozzi, Stefano Indraccolo

Summary: In this study, the expression of five metabolism-associated markers in lung adenocarcinoma PDX samples was investigated. The majority of the analyzed PDX models rely on oxidative phosphorylation metabolism, either alone or in combination with glucose metabolism. This metabolic classification of existing collections of PDX by the mini panel will be useful for pre-clinical testing of metabolism-targeting drugs.

FRONTIERS IN ONCOLOGY (2023)

Article Psychology, Multidisciplinary

The predictive role of intolerance of uncertainty and trait of worry in breast cancer patients: A prospective, observational, single-center clinical study

Malihe Shams, Susanna Pardini, Paola Del Bianco, Caterina Calabrese, Gian Luca De Salvo, Caterina Novara

Summary: The present study aimed to evaluate the worry content, depression, anxiety, and post-traumatic stress symptoms of breast cancer patients and define the role of worry trait and intolerance of uncertainty. The results showed that levels of worry trait and intolerance of uncertainty were associated with maintaining high levels of depression, anxiety, and post-traumatic disorders. Therefore, early assessment of these factors is critical in identifying patients at a higher psychopathological risk.

FRONTIERS IN PSYCHOLOGY (2023)

Article Biochemistry & Molecular Biology

Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma

Silvano Fasolato, Paola Del Bianco, Sandro Malacrida, Adriana Mattiolo, Enrico Gringeri, Paolo Angeli, Patrizia Pontisso, Maria Luisa Calabro

Summary: This pilot study aimed to evaluate the predictive value of cytokine profiles for the development of hepatocellular carcinoma (HCC). The results suggest that certain immune modulators may have a protective role in the peritoneal cavity against disease progression leading to HCC development.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biology

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma

Wayne Croft, Hayden Pearce, Sandra Margielewska-Davies, Lindsay Lim, Samantha M. Nicol, Fouzia Zayou, Daniel Blakeway, Francesca Marcon, Sarah Powell-Brett, Brinder Mahon, Reena Merard, Jianmin Zuo, Gary Middleton, Keith Roberts, Rachel M. Brown, Paul Moss

Summary: Pancreatic ductal adenocarcinoma has poor clinical outcome and limited response to immunotherapy. Stromal fibroblasts play a dominant role in the tumor microenvironment and exhibit high transcriptional heterogeneity influenced by tumor proximity. Targeting tumor-proximal fibroblast subsets, along with HIF-1 alpha inhibition and immune stimulation, may offer a multimodal therapeutic approach for this disease.
Article Gastroenterology & Hepatology

The impact of anastomotic leak on long-term oncological outcomes after low anterior resection for mid-low rectal cancer: extended follow-up of a randomised controlled trial

Quoc Riccardo Bao, Gianluca Pellino, Gaya Spolverato, Angelo Restivo, Simona Deidda, Giulia Capelli, Cesare Ruffolo, Francesco Bianco, Dajana Cuicchi, Elio Jovine, Raffaele Lombardi, Claudio Belluco, Antonio Amato, Filippo La Torre, Corrado Asteria, Aldo Infantino, Tania Contardo, Paola Del Bianco, Paolo Delrio, Salvatore Pucciarelli

Summary: Anastomotic leaks do not affect long-term overall survival, disease-free survival, and local and distant recurrence in patients with mid-low rectal cancer who undergo low anterior resection.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2022)

暂无数据